Dolby Laboratories (DLB) Asset Writedowns and Impairment (2016 - 2025)
Dolby Laboratories' Asset Writedowns and Impairment history spans 17 years, with the latest figure at $792000.0 for Q4 2025.
- For Q4 2025, Asset Writedowns and Impairment rose 8.49% year-over-year to $792000.0; the TTM value through Dec 2025 reached $2.5 million, down 11.83%, while the annual FY2025 figure was $2.4 million, N/A changed from the prior year.
- Asset Writedowns and Impairment reached $792000.0 in Q4 2025 per DLB's latest filing, up from -$148000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $16.9 million in Q3 2023 to a low of -$2.3 million in Q3 2021.
- Average Asset Writedowns and Impairment over 5 years is $912800.0, with a median of $631000.0 recorded in 2024.
- The largest YoY upside for Asset Writedowns and Impairment was 1132.34% in 2023 against a maximum downside of 234.63% in 2023.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $1.6 million in 2021, then tumbled by 166.07% to -$1.0 million in 2022, then tumbled by 103.98% to -$2.1 million in 2023, then soared by 134.75% to $730000.0 in 2024, then rose by 8.49% to $792000.0 in 2025.
- Per Business Quant, the three most recent readings for DLB's Asset Writedowns and Impairment are $792000.0 (Q4 2025), -$148000.0 (Q3 2025), and $615000.0 (Q2 2025).